Delivery Order SPE2DB20D2104-SPE2DB25FMZKC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $60,425.21 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on July 29, 2025, for Bridion 500 mg/5 mL vials, with a ceiling value of $35,252.62 under firm fixed-price terms. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This competitively awarded, non-set-aside delivery order is...
- The Defense Logistics Agency awarded a $22,659.00 delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 mL vials on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $8,543.95 on September 3, 2025, for the supply of Bridion 200 mg/2 ml vials. This non-set-aside, competitively awarded contract carries a firm fixed price and is scheduled for ultimate completion on September 4, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 21, 2025, for the supply of Bridion 200mg/2ml (10 units) with a ceiling value of $24,536.83. This firm fixed-price, competitively awarded delivery order is funded by the Defense Logistics Agency's Medical Supply Chain division and is scheduled for completion by August 15, 2025. The contract represents a child order under AmerisourceBergen's larger...
- This delivery order, awarded on August 20, 2025, to AmerisourceBergen Drug Corp, procures Bridion 200 mg/2 ml vials totaling $1,677.58 under a firm fixed price arrangement. The contract is funded by the Defense Logistics Agency's Medical Supply Chain, a Defense Department organization responsible for pharmaceutical and medical supply distribution to military healthcare systems. The award represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $18,234.69 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Bridion 200 mg/2 ml vials. The contract is a firm fixed price, non-set-aside award with an ultimate completion date of August 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials, valued at $13,599.02 under firm fixed price terms. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $37,940.60 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Bridion 500 mg/5 mL vials. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract falls under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $8,288.57 to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 ml vials on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMZKCDelivery Order
The Defense Logistics Agency awarded a $1,095.66 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Bridion 200 mg/2 mL vials. This firm fixed-price delivery order, which is expected to be completed by September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal pharmaceutical procurement requirements. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor headquartered in Conshohocken, Pennsylvania, serving as a primary supplier to military and veteran healthcare systems. The company holds a prime IDC valued at $999,999,999.00 with DLA Troop Support Medical through December 2026, designated as SPE2DX, which provides comprehensive global pharmaceutical support including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This delivery order for Bridion, a neuromuscular reversal agent used in anesthesia, exemplifies the company's ongoing role in supporting Defense Health Agency operations and broader federal healthcare procurement needs through a flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/3/25 |